AIM ImmunoTech Inc. — Form 10-Q
Filed August 7, 2026 · analyzed by the Periodic Agent
10-Q
▼ Likely negative
significance 42/100
What the filing says
AIM ImmunoTech Inc. and Maxim Group LLC mutually terminated their Equity Distribution Agreement (dated April 1, 2023) effective August 15, 2026. The filing provides no dollar amounts, share counts, or specifics on capital raised under the agreement or reasons for termination. This was a standard at-the-market (ATM) offering facility that is no longer available to the company.
Why this rating
Loss of equity financing option for a $6.4M market-cap company with likely limited capital access. Moderate concern but termination terms unclear; no disclosure of unfulfilled capacity or financial impact.
See more from August 7, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.